Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Evotec Appoints Ingrid Müller COO
Business Executive appointment

Evotec Appoints Ingrid Müller COO

Analysis based on 7 articles · First reported Apr 15, 2026 · Last updated Apr 15, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The appointment of Dr. Ingrid Müller as COO is expected to positively impact Evotec's stock price due to anticipated improvements in operational efficiency and strategic execution. This move signals a commitment to growth and enhanced delivery within the biotechnology sector.

Biotechnology Pharmaceuticals
Event Summary

Evotec SE announced the appointment of Dr. Ingrid Müller as its new Chief Operating Officer (COO), effective May 1, 2026. Dr. Müller brings over 20 years of international leadership experience in the life sciences industry, with previous roles at CureVac, Sanofi, and Fresenius===Fresenius (company). In her new role, she will oversee Evotec's global operations and the implementation of the Horizon initiative, focusing on quality, productivity, scalability, and technological advancements. CEO Dr. Christian Wojczewski emphasized that Dr. Müller's expertise in operational efficiency and strategic understanding will be crucial for Evotec's continued growth transformation and the execution of its strategy in the coming years.

Key Actions
100 Evotec appointed Chief Operating Officer Ingrid Müller
90 Ingrid Müller joined Management Board Evotec
Entities Involved
stock
Evotec
Evotec has appointed Dr. Ingrid Müller as its new Chief Operating Officer, which is expected to strengthen its global operations, scientific capabilities, and the execution of its Horizon initiative, contributing to its growth transformation.
Importance 100 Sentiment 20
per
Ingrid Müller
Dr. Ingrid Müller has been appointed as the Chief Operating Officer of Evotec, bringing over 20 years of international leadership experience in the life sciences industry. She will oversee Evotec's global operations and the Horizon initiative.
Importance 95 Sentiment 20
per
Christian Wojczewski
Dr. Christian Wojczewski, CEO of Evotec, welcomed Dr. Ingrid Müller, highlighting her strategic perspective and operational discipline as complementary to Evotec's growth transformation.
Importance 30 Sentiment 10
stock
CureVac
Dr. Ingrid Müller previously served as Vice President Portfolio Strategy & Execution at CureVac.
Importance 10 Sentiment 0
stock
Sanofi
Dr. Ingrid Müller held senior international leadership roles at Sanofi prior to joining Evotec.
Importance 10 Sentiment 0
subs
Fresenius===Fresenius (company)
Dr. Ingrid Müller held senior international leadership roles at Fresenius===Fresenius (company), where she contributed to strengthening supply resilience and achieving savings.
Importance 10 Sentiment 0
Relationships
Ingrid Müller related ↔ Evotec
Christian Wojczewski related ↔ Evotec
Ingrid Müller related ↔ CureVac
Ingrid Müller related ↔ Sanofi
Ingrid Müller related ↔ Fresenius===Fresenius (company)
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.